Protein-ligand binding affinity predictions by implicit solvent simulations: a tool for lead optimization?

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2006-11-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM061021SPMID 17149872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design.

  2006cited by this paper
• Estimation of Absolute Free Energies of Hydration Using Continuum Methods:  Accuracy of Partial Charge Models and Optimization of Nonpolar Contributions.

  2006cited by this paper
• Continuum solvation models in the linear interaction energy method.

  2006cited by this paper
• Efficient Generalized Born Models for Monte Carlo Simulations.

  2006cited by this paper
• MM/PBSA analysis of molecular dynamics simulations of bovine β‐lactoglobulin: Free energy gradients in conformational transitions?

  2005cited by this paper
• Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase.

  2005cited by this paper
• Calculation of absolute protein-ligand binding free energy from computer simulations.

  2005cited by this paper
• Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.

  2005cited by this paper
• Limitations of atom-centered dielectric functions in implicit solvent models.

  2005cited by this paper
• Validation and use of the MM-PBSA approach for drug discovery.

  2005cited by this paper
• Exploring protein native states and large‐scale conformational changes with a modified generalized born model

  2004cited by this paper
• Structural and energetic analyses of the effects of the K103N mutation of HIV-1 reverse transcriptase on efavirenz analogues.

  2004cited by this paper
• Virtual Screening Using Protein-Ligand Docking: Avoiding Artificial Enrichment

  2004cited by this paper
• 2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activity.

  2004cited by this paper
• Proton binding to proteins: pK(a) calculations with explicit and implicit solvent models.

  2004cited by this paper
• Development and testing of a general amber force field

  2004cited by this paper
• The parameterization and validation of generalized born models using the pairwise descreening approximation

  2004cited by this paper
• Efficient evaluation of binding free energy using continuum electrostatics solvation.

  2004cited by this paper
• Improved protein–ligand docking using GOLD

  2003cited by this paper
• Free energy calculations for theophylline binding to an RNA aptamer: Comparison of MM-PBSA and thermodynamic integration methods.

  2003cited by this paper
• The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators

  2002cited by this paper
• A review of protein-small molecule docking methods

  2002cited by this paper
• Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system.

  2001cited by this paper
• The configurational dependence of binding free energies: A Poisson–Boltzmann study of Neuraminidase inhibitors

  2001cited by this paper
• An analysis of the interactions between the Sem-5 SH3 domain and its ligands using molecular dynamics, free energy calculations, and sequence analysis.

  2001cited by this paper
• Generalized born models of macromolecular solvation effects.

  2000cited by this paper
• Recent advances in structure-based rational drug design.

  2000cited by this paper
• Investigating the binding specificity of U1A-RNA by computational mutagenesis.

  2000cited by this paper
• Predicting relative binding affinities of non-peptide HIV protease inhibitors with free energy perturbation calculations

  1999cited by this paper
• Binding constants of neuraminidase inhibitors: An investigation of the linear interaction energy method.

  1999cited by this paper
• Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7.

  1999cited by this paper
• Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation.

  1999cited by this paper
• Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations.

  1998cited by this paper
• Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.

  1998cited by this paper
• Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model

  1998cited by this paper
• Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.

  1998cited by this paper
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

  1997cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996cited by this paper
• VMD: visual molecular dynamics.

  1996cited by this paper
• Class IV charge models: A new semiempirical approach in quantum chemistry

  1995cited by this paper
• A new method for predicting binding affinity in computer-aided drug design.

  1994cited by this paper
• Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

  1994cited by this paper
• NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

  1994cited by this paper
• Free energy perturbation calculations on binding and catalysis after mutating Asn 155 in subtilisin

  1987cited by this paper
• Evidence for kinks in DNA folding in the nucleosome

  1987cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Advancements in Computer-Aided Drug Design: A Comprehensive Review

  2025cites this paper
• ABCG2: A Milestone Charge Model for Accurate Solvation Free Energy Calculation

  2025cites this paper
• A Full-Spectrum Generative Lead Discovery (FSGLD) Pipeline via DRUG-GAN: A Multiscale Method for Drug-like/Target-specific Compound Library Generation

  2025cites this paper
• Peptide Drug Design Using Alchemical Free Energy Calculation: An Application and Validation on Agonists of Ghrelin Receptor

  2024cites this paper
• Development and test of highly accurate endpoint free energy methods. 1: Evaluation of ABCG2 charge model on solvation free energy prediction and optimization of atom radii suitable for more accurate solvation free energy prediction by the PBSA method

  2023cites this paper
• End-Point Free Energy Prediction using PB and MSSAS

  2022cites this paper
• An In-Silico Approach to Evaluate the Inhibitory Potency of Selected Hydroxamic Acid Derivatives on Zinc-Dependent Histone Deacetylase Enzyme

  2021cites this paper
• Sensitivity of Binding Free Energy Calculations to Initial Protein Crystal Structure.

  2021cites this paper
• Incorporating structural similarity into a scoring function to enhance the prediction of binding affinities

  2021cites this paper
• Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction

  2021cites this paper
• Molecular Docking in Drug Discovery

  2021cites this paper
• Determination of van der Waals Parameters Using a Double Exponential Potential for Nonbonded Divalent Metal Cations in TIP3P Solvent.

  2021cites this paper
• Is structure based drug design ready for selectivity optimization?

  2020cites this paper
• Combining Machine Learning and Enhanced Sampling Techniques for Efficient and Accurate Calculation of Absolute Binding Free Energies

  2020cites this paper
• Fast, Accurate, and Reliable Protocols for Routine Calculations of Protein–Ligand Binding Affinities in Drug Design Projects Using AMBER GPU-TI with ff14SB/GAFF

  2020cites this paper
• How Well Does the Extended Linear Interaction Energy Method Perform in Accurate Binding Free Energy Calculations?

  2020cites this paper
• A fast and high-quality charge model for the next generation general AMBER force field.

  2020cites this paper
• Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective.

  2019cites this paper
• Molecular Modeling and Drug Design Techniques in Microbial Drug Discovery

  2019cites this paper
• Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies

  2018cites this paper
• Understanding the hydrogen transfer mechanism for the biodegradation of 2,4,6-trinitrotoluene catalyzed by pentaerythritol tetranitrate reductase: molecular dynamics simulations.

  2018cites this paper
• Fast Pairwise Approximation of Solvent Accessible Surface Area for Implicit Solvent Simulations of Proteins on CPUs and GPUs.

  2018cites this paper
• Comparison of Accuracy and Convergence Rate between Equilibrium and Nonequilibrium Alchemical Transformations for Calculation of Relative Binding Free Energy

  2017cites this paper
• Review of Theoretical Models to Study Natural Products with Antiprotozoal Activity.

  2017cites this paper
• Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations

  2017cites this paper
• Impact of domain knowledge on blinded predictions of binding energies by alchemical free energy calculations

  2017cites this paper
• Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations

  2017cites this paper
• Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

  2016cites this paper
• Alchemical Free Energy Calculations : Ready for Prime Time ?

  2016cites this paper
• Predicting binding free energies: Frontiers and benchmarks

  2016cites this paper
• Elucidation of Nonadditive Effects in Protein-Ligand Binding Energies: Thrombin as a Case Study.

  2016cites this paper
• How a Kinase Inhibitor Withstands Gatekeeper Residue Mutations.

  2016cites this paper
• Docking and Ligand Binding Affinity: Uses and Pitfalls

  2016cites this paper
• - MM-GB/SA Rescoring of Docking Poses: Tricks of the Trade

  2015cites this paper
• Multi Activity QSAR Models for Anti- Parasite Drugs Using Markov Entropy Indices

  2015cites this paper
• Rapid alchemical free energy calculation employing a generalized born implicit solvent model.

  2015cites this paper
• Generalized Born and Explicit Solvent Models for Free Energy Calculations in Organic Solvents: Cyclodextrin Dimerization.

  2015cites this paper
• Design and application of implicit solvent models in biomolecular simulations

  2014cites this paper
• A Large-Scale Test of Free-Energy Simulation Estimates of Protein-Ligand Binding Affinities

  2014cites this paper
• Rapid decomposition and visualisation of protein-ligand binding free energies by residue and by water.

  2014cites this paper
• Scoring multipole electrostatics in condensed-phase atomistic simulations.

  2013cites this paper
• How to Calculate Binding Constants for Drug Discovery Studies

  2013cites this paper
• The Drug Discovery Process

  2013cites this paper
• Free Energy Methods in Ligand Design

  2013cites this paper
• Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

  2013cites this paper
• Solvent fluctuations in hydrophobic cavity–ligand binding kinetics

  2013cites this paper
• Advances and applications of binding affinity prediction methods in drug discovery.

  2012cites this paper
• Macromolecular association equilibria: from chimeric HRV:HIV virus/antibody interactions to modeling of protein-ligand binding free energies

  2012cites this paper
• 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.

  2012cites this paper
• Molecular-level simulation of pandemic influenza glycoproteins.

  2012cites this paper
• A Direct Comparison of the MM-GB/SA Scoring Procedure and Free-Energy Perturbation Calculations Using Carbonic Anhydrase as a Test Case: Strengths and Pitfalls of Each Approach.

  2011cites this paper
• Predicting Fragment Binding Poses Using a Combined MCSS MM-GBSA Approach

  2011cites this paper
• An estimation method of binding free energy in terms of ABEEMσπ/MM and continuum electrostatics fused into LIE method

  2011cites this paper
• NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.

  2011cites this paper
• Advances in all atom sampling methods for modeling protein-ligand binding affinities.

  2011cites this paper
• Predicting the effects of basepair mutations in DNA-protein complexes by thermodynamic integration.

  2011cites this paper
• A simple QM/MM approach for capturing polarization effects in protein-ligand binding free energy calculations.

  2011cites this paper
• Free energy calculations offer insights into the influence of receptor flexibility on ligand–receptor binding affinities

  2011cites this paper
• Binding Affinities of Factor Xa Inhibitors Estimated by Thermodynamic Integration and MM/GBSA

  2011cites this paper
• Alchemical free energy methods for drug discovery: progress and challenges.

  2011cites this paper
• A water-swap reaction coordinate for the calculation of absolute protein-ligand binding free energies.

  2011cites this paper
• Molecular docking: a powerful approach for structure-based drug discovery.

  2011cites this paper
• Molecular simulations for the evaluation of binding free energies in lead optimization

  2011influential citation
• Application of Models for Biomolecular Structure and Interactions to Understand and Influence Biological Function

  2011cites this paper
• Accounting for water molecules in drug design

  2011cites this paper
• MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.

  2011cites this paper
• Conformational Dynamics and Ligand Binding in the Multi-Domain Protein PDC109

  2010cites this paper
• Prediction of protein–ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations

  2010cites this paper
• Nonpolar Solvation Free Energies of Protein-Ligand Complexes.

  2010cites this paper
• Accounting for ligand conformational restriction in calculations of protein-ligand binding affinities.

  2010cites this paper
• Computational analyses of protein-ligand interactions

  2010cites this paper
• Rigorous Free Energy Calculations in Structure‐Based Drug Design

  2010cites this paper
• Mixed Quantum-Classical Calculations in Biological Systems

  2009cites this paper
• Assessment of nonequilibrium free energy methods.

  2009cites this paper
• Optimal sampling efficiency in Monte Carlo simulation with an approximate potential.

  2009cites this paper
• Dewetting-controlled binding of ligands to hydrophobic pockets.

  2009cites this paper
• Study of MDM2 Binding to p53-Analogues: Affinity, Helicity, and Applicability to Drug Design

  2009cites this paper
• Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization.

  2009cites this paper
• Prediction of the water content in protein binding sites.

  2009cites this paper
• Protein-ligand binding affinity by nonequilibrium free energy methods.

  2008cites this paper
• Hierarchical Structure-Based Virtual Screening for Drug Design

  2008cites this paper
• A facile preparation of trans-1,2-cyclopropanes containing p-trifluoromethylphenyl group and its application to the construction of pyrazole and cyclopropane ring fused pyridazinone derivatives

  2008cites this paper
• Calculation of absolute ligand binding free energy to a ribosome-targeting protein as a function of solvent model.

  2008cites this paper
• Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery.

  2008cites this paper
• Hit identification and binding mode predictions by rigorous free energy simulations.

  2008cites this paper
• Optimizing the Signal-to-Noise Ratio of Scoring Functions for Protein-Ligand Docking

  2008cites this paper
• Structure-Based Discovery of Novel Non-nucleosidic DNA Alkyltransferase Inhibitors: Virtual Screening and in Vitro and in Vivo Activities

  2008cites this paper
• An efficient method for the calculation of quantum mechanics/molecular mechanics free energies.

  2008cites this paper
• Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go

  2008cites this paper
• Comparative molecular dynamics simulations of histone deacetylase‐like protein: Binding modes and free energy analysis to hydroxamic acid inhibitors

  2008cites this paper
• Physics-based methods for studying protein-ligand interactions.

  2007cites this paper
• Chapter 4 Alchemical Free Energy Calculations: Ready for Prime Time?

  2007cites this paper
• Molecular modeling of hydration in drug design.

  2007cites this paper
• Monte Carlo-based linear Poisson-Boltzmann approach makes accurate salt-dependent solvation free energy predictions possible.

  2007cites this paper
• Protein-Ligand Complexes:  Computation of the Relative Free Energy of Different Scaffolds and Binding Modes.

  2007cites this paper
• Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress

  2007cites this paper
• Implementation of the SCC-DFTB method for hybrid QM/MM simulations within the amber molecular dynamics package.

  2007cites this paper